{
    "id": "dbpedia_1740_0",
    "rank": 75,
    "data": {
        "url": "https://lupus.bmj.com/content/1/1/e000027.short",
        "read_more_link": "",
        "language": "en",
        "title": "Lower vitamin D levels are associated with higher systemic lupus erythematosus activity, but not predictive of disease flare-up",
        "top_image": "",
        "meta_img": "",
        "images": [
            "https://lupus.bmj.com/sites/default/themes/bmjj/img/logos/logo-bmj-journals.svg",
            "https://resources.bmj.com/repository/journals-network-project/images/journal-logos/logo-lupus.svg",
            "https://lupus.bmj.com/sites/default/themes/bmjj/img/icon-pdf.png",
            "https://lupus.bmj.com/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif",
            "https://resources.bmj.com/repository/journals-network-project/images/society-logos/society-logo-lupus.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [
            "Laurent Perard",
            "Hélène Desmurs-Clavel",
            "Du Le Thi Huong",
            "Bouchra Asli",
            "Jean-Emmanuel Kahn",
            "Laurent Sailler",
            "Félix Ackermann",
            "Thomas Papo",
            "Karim Sacré",
            "Olivier Fain"
        ],
        "publish_date": "2014-06-01T00:00:00",
        "summary": "",
        "meta_description": "Objectives Growing evidence suggests that vitamin D plays a key role in the pathogenesis and progression of autoimmune diseases, including systemic lupus erythematosus (SLE). Recent studies have found an association between lower serum 25-hydroxyvitamin D (25(OH)D) levels and higher SLE activity. We studied the relationship between 25(OH)D levels and Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) score, and we assessed for the first time the role of vitamin D in predicting SLE flare-ups.\n\nMethods Serum 25(OH)D levels were measured in 170 patients with SLE who were prospectively followed up for 6 months (Plaquenil LUpus Systemic study, ClinicalTrials.gov number [NCT00413361][1]).\n\nResults The mean SLEDAI score was 2.03±2.43 and 12.3% patients had active disease (SLEDAI ≥6). The mean 25(OH)D level was 20.6±9.8 ng/mL. Deficiency (25(OH)D <10 ng/mL) was observed in 27 (15.9%), insufficiency (10≤25(OH)D<30) in 112 (65.9%) and optimal vitamin D status (25(OH)D≥30) in 31 (18.2%) patients. In multivariate analysis, female gender (p=0.018), absence of defined antiphospholipid syndrome (p=0.002) and higher creatinine clearance (p=0.004) were predictive of lower 25(OH)D levels. In multivariate analysis, lower 25(OH)D levels were associated with high SLE activity (p=0.02). Relapse-free survival rate was not statistically different according to the vitamin D status during the 6-month follow-up (p=0.22).\n\nConclusions We found a low vitamin D status in the majority of patients with SLE, and a modest association between lower 25(OH)D levels and high disease activity. There was no association between baseline 25(OH)D levels and relapse-free survival rate.\n\n [1]: /lookup/external-ref?link_type=CLINTRIALGOV&access_num=NCT00413361&atom=%2Flupusscimed%2F1%2F1%2Fe000027.atom",
        "meta_lang": "en",
        "meta_favicon": "https://lupus.bmj.com/sites/default/themes/bmjj/favicon.ico",
        "meta_site_name": "Lupus Science & Medicine",
        "canonical_link": "https://lupus.bmj.com/content/1/1/e000027",
        "text": "Yoland Schoindre1,2,\n\nMoez Jallouli1,3,\n\nMarie-Laure Tanguy4,\n\nPascale Ghillani5,\n\nLionel Galicier6,7,\n\nOlivier Aumaître8,9,\n\nCamille Francès1,10,\n\nVéronique Le Guern11,12,\n\nFrédéric Lioté6,13,\n\nAmar Smail14,\n\nNicolas Limal15,\n\nLaurent Perard16,\n\nHélène Desmurs-Clavel16,\n\nDu Le Thi Huong1,3,\n\nBouchra Asli6,7,\n\nJean-Emmanuel Kahn17,\n\nLaurent Sailler18,19,\n\nFélix Ackermann17,\n\nThomas Papo6,20,\n\nKarim Sacré6,20,\n\nOlivier Fain21,22,\n\nJérôme Stirnemann21,22,\n\nPatrice Cacoub1,3,\n\nGaëlle Leroux1,2,\n\nJudith Cohen-Bittan1,3,\n\nJean-Sébastien Hulot1,23,\n\nPhilippe Lechat1,23,\n\nLucile Musset5,\n\nJean-Charles Piette1,3,\n\nZahir Amoura1,3,\n\nJean-Claude Souberbielle11,24 and\n\nNathalie Costedoat-Chalumeau1,3\n\n1UPMC, Université Paris 6, Paris, France\n\n2AP-HP, Hôpital Pitié-Salpêtrière, Service de Médecine Interne 1, 47–83 Boulevard de l'Hôpital, Paris, Cedex, France\n\n3AP-HP, Hôpital Pitié-Salpêtrière, Centre de référence national pour le Lupus Systémique et le syndrome des Antiphospholipides, Service de Médecine Interne 2, 47–83 Boulevard de l'Hôpital, Paris, Cedex, France\n\n4AP-HP, Hôpital Pitié-Salpêtrière, Unité de recherche clinique, 47–83 Boulevard de l'Hôpital, Paris, Cedex, France\n\n5AP-HP, Hôpital Pitié-Salpêtrière, Laboratoire d'Immunochimie, 47–83 Boulevard de l'Hôpital, Paris, Cedex, France\n\n6Université Paris Diderot, Sorbonne Paris Cité, Paris, France\n\n7AP-HP, Hôpital Saint-Louis, Service d'Immunologie Clinique, 1 avenue Claude Vellefaux, Paris, France\n\n8Université de Clermont-Ferrand, Clermont-Ferrand, France\n\n9CHU Clermont-Ferrand, Hôpital Gabriel Montpied, service de Médecine Interne, Clermont-Ferrand, Cedex, France\n\n10AP-HP, Hôpital Tenon, Service de Dermatologie Allergologie, Paris, France\n\n11Université Paris Descartes, Sorbonne Paris Cité, Paris, France\n\n12AP-HP, Hôpital Cochin, Service de Médecine Interne, Paris, France\n\n13AP-HP, Hôpital Lariboisière, Service de Rhumatologie, Paris, France\n\n14CHU Amiens, Hôpital Nord, Service de Médecine Interne, Place Victor Pauchet, Amiens, France\n\n15AP-HP, Hôpital Henri Mondor, Service de Médecine Interne, Créteil, France\n\n16Hospices Civils de Lyon, Groupement Hospitalier Edouard Herriot, Service de Médecine Interne, Lyon, France\n\n17Université Versailles-Saint-Quentin-en-Yvelines, Hôpital Foch, Service de Médecine Interne, Suresnes, Cedex, France\n\n18Université Paul-Sabatier, Toulouse, France\n\n19CHU Toulouse, Hôpital Purpan, Service de Médecine Interne, Place Dr Baylac, Toulouse, France\n\n20AP-HP, Hôpital Bichat Claude-Bernard, Service de Médecine Interne, Paris, France\n\n21Université Paris Nord, Sorbonne Paris Cité, France\n\n22AP-HP, Hôpital Jean-Verdier, Service de Médecine Interne, Bondy, France\n\n23AP-HP, Hôpital Pitié-Salpêtrière, Service de Pharmacologie, Paris, Cedex, France\n\n24AP-HP, Hôpital Necker-Enfants Malades, Laboratoire de Physiologie, Paris, France\n\nCorrespondene to Professor Nathalie Costedoat-Chalumeau, nathalie.costedoat{at}gmail.com\n\nhttps://doi.org/10.1136/lupus-2014-000027\n\nStatistics from Altmetric.com"
    }
}